➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Merck
AstraZeneca
Moodys
Boehringer Ingelheim

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ZABOFLOXACIN


Email this page to a colleague

« Back to Dashboard

Clinical Trials for Zabofloxacin

Trial ID Title Status Sponsor Phase Summary
NCT01081964 ↗ Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia Terminated IASO Pharma Inc. Phase 2 A double-blind, three-arm study, to evaluate the safety and efficacy of two dosing regimens of zabofloxacin (a fluoroquinolone antibiotic) in community acquired pneumonia.
NCT01341249 ↗ A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a Completed Dong Wha Pharmaceutical Co. Ltd. Phase 1 The purpose of this study is to compare and explore pharmacokinetics of zabofloxacin, the main component of DW224aa(Test drug) and DW224a(Reference drug).
NCT01341249 ↗ A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a Completed Seoul National University Hospital Phase 1 The purpose of this study is to compare and explore pharmacokinetics of zabofloxacin, the main component of DW224aa(Test drug) and DW224a(Reference drug).
NCT01658020 ↗ A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg Completed Ajou University Phase 3 The purpose of this study is to Evaluate the Efficacy and Safety Profiles of oral multiple dose of Zabofloxacin Tablet 400 mg.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Zabofloxacin

Condition Name

Condition Name for
Intervention Trials
Healthy 2
Community Acquired Pneumonia 1
Chronic Obstructive Pulmonary Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Lung Diseases 1
Pneumonia 1
Pulmonary Disease, Chronic Obstructive 1
Lung Diseases, Obstructive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Zabofloxacin

Trials by Country

Trials by Country for
Location Trials
United States 10
Korea, Republic of 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
New Jersey 1
Michigan 1
Indiana 1
Idaho 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Zabofloxacin

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 3
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zabofloxacin

Sponsor Name

Sponsor Name for
Sponsor Trials
Dong Wha Pharmaceutical Co. Ltd. 3
Kangdong Sacred Heart Hospital 1
Chonbuk National University Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Other 31
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Colorcon
Harvard Business School
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.